Skip to main content
. 2019 Nov 21;14(11):e0225457. doi: 10.1371/journal.pone.0225457

Table 2. Demographic data of the participants enrolled for preimplantation genetic testing for beta thalassemia/hemoglobin E disease.

Average maternal age (years ± SD) 34.87 ± 3.56
Average paternal age (years ± SD) 36.20 ± 3.08
Underlying gynecological condition [n (%)]
 • Endometriosis 1 (6.67)
 • None 14 (93.33)
Experience on previous natural conception and pregnancy
 • Yes 7 (46.67)
 • No 8 (53.33)
Number of current living child(ren) [n (%)]
 • 0 12 (80)
 • 1 2 (13.33)
 • 2 1 (6.67)
Reasons for referral [n (%)]
 • Experience on thalassemia 7 (46.67)
 • Carrier status found during preconception screening 8 (53.33)
Experience of thalassemia in the family [n (%)]
 • Recent experience on prenatal diagnosis and termination of pregnancy 4 (26.67)
 • Current children affected by thalassemia disease 2 (13.33)
 • Current children affected by thalassemia trait 1 (6.67)
 • No experience 8 (53.33)
Type of beta thalassemia mutation [n (%)]
 • c.126_129delCTTT 3 (20)
 • c.52A>T 4 (26.67)
 • c.316-197 C>T 5 (33.33)
 • c.2T>G 1 (6.67)
 • c.92+5 G>C 1 (6.67)
 • Whole gene deletion 1 (6.67)